Public list Rare Diseases (230):
Karos Pharmaceuticals is a privately held biopharmaceutical company developing therapeutic agents to modulate peripheral serotonin synthesis to treat orphan indications, including pulmonary arterial hypertension (PAH) and carcinoid syndrome.
Company (Alive / Active)
5 Science Park #2
New Haven, 06511
Connecticut, United States
|Title||Application Date||Patent Date||Status
(Patent / Application)